advertisement
11.4 Prostaglandins (32)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins47967 Effect of latanoprost on choroidal blood flow regulation in healthy subjects
Boltz A; Schmidl D; Weigert G; Lasta M; Pemp B; Resch H; Garhofer G; Fuchsjager-Mayrl G; Schmetterer L
Investigative ophthalmology & visual science 2011; 52: 4410-4415
47865 Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
Mizoguchi T; Ozaki M; Wakiyama H; Ogino N
Clinical Ophthalmology 2011; 5: 1515-1520
47815 Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 499-502
48067 Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost
Aihara M; Shirato S; Sakata R
Japanese Journal of Ophthalmology 2011; 55: 600-604
47931 Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases
Schwartz GF; Kotak S; Mardekian J; Fain JM
BMC Ophthalmology 2011; 11: 14
47728 Central serous chorioretinopathy associated with topical latanoprost therapy
Artunay O; Senel A; Sengul A; Rasier R; Bahcecioglu H
Ocular Immunology and Inflammation 2011; 19: 453-455
47688 Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma
Huang HL; Sun XH; Xiao M
Chinese Journal of Ophthalmology 2011; 47: 109-113
47930 A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy
Fain JM; Kotak S; Mardekian J; Bacharach J; Edward DP; Rauchman S; Brevetti T; Fox JL; Lovelace C
BMC Ophthalmology 2011; 11: 13
48009 The biology, pathology and therapeutic use of prostaglandins in the eye
Toris CB; Gulati V
Clinical Lipidology 2011; 6: 577-591
47754 Prostaglandin analogs
Shah B; Arora V; Wadhwani M; Mishra SK
Journal of Current Glaucoma Practice 2011; 5: 15-20
48282 Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature
Tressler CS; Wiseman RL; Dombi TM; Jessen B; Huang K; Kwok KK; Wirostko BM
British Journal of Ophthalmology 2011; 95: 1490-1495
47816 Do prostaglandin analogs affect eyelid position and motility?
Altieri M; Ferrari E
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 511-517
48027 Heart block following topical latanoprost treatment
De Smit E; Theodorou M; Hildebrand GD; Bloom P
British Medical Journal (Clinical Research Edition) Case Reports 2011;
47832 Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquad(registered trademark) instead of benzalkonium chloride in Germany
Gerlier L; Lamotte M; Lorenz K; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A503
48337 Effect of acute increases of intraocular pressure on corneal pachymetry in eyes treated with travoprost: an animal study
Bolívar G; Teus M; Arranz-Marquez E
Current Eye Research 2011; 36: 1014-1019
47783 A short-term randomized clinical trial of daily versus alternate day use of travoprost 0.004% in the treatment of ocular hypertension
Khairy HA; Said-Ahmed K
Journal of Glaucoma 2011;
47603 Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients
Popa SA; Bucatariu PM; Azoicahi D; Costin D; Manole A; Matei M; Merchez M
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2011; 115: 455-459
47711 The use of prostaglandin analogs in the uveitic patient
Horsley MB; Chen TC
Seminars in Ophthalmology 2011; 26: 285-289
47854 Latanoprost 0.005% test formulation is as effective as Xalatan((registered trademark)) in patients with ocular hypertension and primary open-angle glaucoma
Allaire C; Dietrich A; Allmeier H; Grundmane I; Mazurpiotrowska G; Neshev P; Kahle G
European Journal of Ophthalmology 2011; 22: 19-27
47652 Balancing efficacy and tolerability of prostaglandin analogues and prostaglandintimolol fixed combinations in primary open-angle glaucoma
Aptel F; Denis P
Current Medical Research and Opinion 2011; 27: 1949-1958
47924 Tafluprost for glaucoma
Papadia M; Bagnis A; Scotto R; Traverso CE
Expert Opinion in Pharmacotherapy 2011; 12: 2393-2401
48377 Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction
Yamagishi R; Aihara M; Araie M
Experimental Eye Research 2011; 93: 265-270
47596 Effect of Ketorolac Add-On Treatment on Intra-Ocular Pressure in Glaucoma Patients Receiving Prostaglandin Analogues
Turan-Vural E; Torun-Acar B; Acar S
Ophthalmologica 2011;
48283 Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models
Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
Experimental Eye Research 2011; 93: 250-255
48336 Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Current Eye Research 2011; 36: 979-988
